Cholesteryl Ester Storage DiseaseSymptoms, Doctors, Treatments, Advances & More
Cholesteryl Ester Storage Disease Overview
Learn About Cholesteryl Ester Storage Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Barbara Burton is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Burton is rated as an Elite provider by MediFind in the treatment of Cholesteryl Ester Storage Disease. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.
Anais Brassier practices practicing medicine in Paris, France. Ms. Brassier is rated as an Elite expert by MediFind in the treatment of Cholesteryl Ester Storage Disease. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Wolman Disease, Lysosomal Acid Lipase Deficiency, Cholesteryl Ester Storage Disease, Kidney Transplant, and Liver Transplant.
Francois Feillet practices practicing medicine in Nancy, France. Mr. Feillet is rated as an Elite expert by MediFind in the treatment of Cholesteryl Ester Storage Disease. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Cholesteryl Ester Storage Disease, Lysosomal Acid Lipase Deficiency, Wolman Disease, Gastrostomy, and Liver Transplant.
Summary: A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)
Summary: This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.